New Rule Requires Drug Price Disclosure in TV Ads

May 15, 2019 | Eric D. Fader | Legislation and Public Policy | Medicare and Medicaid | Pharmaceuticals

On May 8, the U.S. Department of Health and Human Services announced a final rule from the Centers for Medicare & Medicaid Services requiring pharmaceutical companies to disclose the list prices of prescription drugs in television advertisements. The rule will apply to all drugs covered by Medicare or Medicaid that cost at least $35 per month or per course of treatment.

The rule will take effect 60 days after it is published in the Federal Register. Pharma industry stakeholders have objected to the requirement, arguing that list prices do not accurately reflect what patients actually pay for their medications.

Share this article:
show more

Get legal updates and news delivered to your inbox